Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT05400109. IPD Sharing: NO. Countries: 1. Publications: 0.
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05524298. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07097363. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04502706. IPD Sharing: NO. Countries: 1. Publications: 0.
PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy
ClinicalTrials.gov study NCT01910025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00278382. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
ClinicalTrials.gov study NCT07041827. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004198. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
ClinicalTrials.gov study NCT05040555. IPD Sharing: NO. Countries: 1. Publications: 0.
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
ClinicalTrials.gov study NCT06834373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
ClinicalTrials.gov study NCT05977673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
ClinicalTrials.gov study NCT05508867. IPD Sharing: YES. Countries: 20. Publications: 0.
A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
ClinicalTrials.gov study NCT00412321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00062114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05169515. IPD Sharing: NO. Countries: 5. Publications: 0.
LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06090162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01238146. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL
ClinicalTrials.gov study NCT06504394. IPD Sharing: YES. Countries: 11. Publications: 0.
Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00082966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00033267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.